Dosing Subcutaneous Immunoglobulin to Achieve Target Levels in Hematopoietic Cell Transplant Recipients
BLOOD CELL THERAPY / The official journal of APBMT · 2026 · 9 (2)
DOI: 10.31547/bct-2025-030 ↗Kurz gefasst
Fachartikel in der Zeitschrift BLOOD CELL THERAPY / The official journal of APBMT, 2026. Verfasst von Shigeo Fuji und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Osaka International Cancer Institute, Osaka, Japan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Osaka International Cancer Institute, Osaka, Japan.
- Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan.
Zitieren
APA
Fuji, S., Suga, M., Tada, Y., Shingai, Y., Kasahara, H., Yuda, S., Yokota, T., & Ishikawa, J. (2026). Dosing Subcutaneous Immunoglobulin to Achieve Target Levels in Hematopoietic Cell Transplant Recipients. BLOOD CELL THERAPY / The official journal of APBMT, 9(2). https://doi.org/10.31547/bct-2025-030
Vancouver
Fuji S, Suga M, Tada Y, Shingai Y, Kasahara H, Yuda S, et al. Dosing Subcutaneous Immunoglobulin to Achieve Target Levels in Hematopoietic Cell Transplant Recipients. BLOOD CELL THERAPY / The official journal of APBMT. 2026;9(2). doi:10.31547/bct-2025-030
BibTeX
@article{Fuji2026,
author = {Fuji, Shigeo and Suga, Makiko and Tada, Yuma and Shingai, Yasuhiro and Kasahara, Hidenori and Yuda, Sayako and Yokota, Takafumi and Ishikawa, Jun},
title = {Dosing Subcutaneous Immunoglobulin to Achieve Target Levels in Hematopoietic Cell Transplant Recipients},
journal = {BLOOD CELL THERAPY / The official journal of APBMT},
year = {2026},
volume = {9},
number = {2},
doi = {10.31547/bct-2025-030}
}
EUVIMED